About This Event
Abeona Therapeutics Inc. (Nasdaq: ABEO) visits the Nasdaq MarketSite in Times Square, commemorating the 10-year anniversary of Abeona’s stock listing on Nasdaq and recognizing the significance of the Company’s potentially first FDA-approved product with an FDA decision date on April 29, 2025.
In honor of the occasion, Vish Seshadri, President and CEO, rings the Closing Bell.